These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17292819)

  • 1. Inflammatory tales of liver cancer.
    Hoffmann A; Xia Y; Verma IM
    Cancer Cell; 2007 Feb; 11(2):99-101. PubMed ID: 17292819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
    Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
    Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
    Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
    Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
    J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular survival pathways in the liver.
    Luedde T; Trautwein C
    Liver Int; 2006 Dec; 26(10):1163-74. PubMed ID: 17105581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
    Elsharkawy AM; Mann DA
    Hepatology; 2007 Aug; 46(2):590-7. PubMed ID: 17661407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
    Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
    Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The association of abnormal activation of hepatocyte nuclear factor-kappa B with hepatocarcinogenesis].
    Yao DF; Su XQ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):539-40. PubMed ID: 16867281
    [No Abstract]   [Full Text] [Related]  

  • 13. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contradictory functions of NF-kappaB in liver physiology and cancer.
    Vainer GW; Pikarsky E; Ben-Neriah Y
    Cancer Lett; 2008 Aug; 267(2):182-8. PubMed ID: 18479806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
    Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK
    Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
    Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
    Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.
    Liedtke C; Plümpe J; Kubicka S; Bradham CA; Manns MP; Brenner DA; Trautwein C
    Hepatology; 2002 Aug; 36(2):315-25. PubMed ID: 12143039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
    Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
    Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
    Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.